Profile data is unavailable for this security.
About the company
Perspective Therapeutics, Inc. is a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents. The Company is focused on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies, so its targeted medical doses are delivered directly to the tumor site. The Company’s core product is its Cesium-131 sealed source brachytherapy seed. These seeds can be inserted individually or in combination into various locations in the body. The Company also sells seeds in strands to keep them from individually moving. The Company’s segments are Brachytherapy and Drug Operations. Brachytherapy includes sales and manufacturing of Cesium-131 brachytherapy seeds, including research and development of new applications for the seeds. Drug Operations includes research and development and clinical operations related to the use of Lead-203 and Lead-212 as a diagnostic and a therapeutic drug.
- Revenue in USD (TTM)8.17m
- Net income in USD-25.10m
- Incorporated2018
- Employees88.00
- LocationPerspective Therapeutics Inc2401 Elliott Avenue, Suite 320SEATTLE 98121United StatesUSA
- Phone+1 (509) 375-1202
- Fax+1 (302) 636-5454
- Websitehttps://isoray.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Treace Medical Concepts Inc | 187.12m | -49.53m | 681.30m | 516.00 | -- | 4.92 | -- | 3.64 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Atrion Corp | 169.33m | 19.41m | 730.29m | 712.00 | 37.65 | 3.01 | 21.16 | 4.31 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| Orthopediatrics Corp | 148.73m | -20.97m | 780.90m | 247.00 | -- | 2.04 | -- | 5.25 | -0.9251 | -0.9251 | 6.56 | 16.13 | 0.3433 | 0.4073 | 5.01 | 602,153.90 | -4.84 | -5.40 | -5.28 | -5.93 | 74.80 | 75.09 | -14.10 | -15.92 | 2.90 | -- | 0.026 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| Silk Road Medical Inc | 185.49m | -53.42m | 799.88m | 474.00 | -- | 5.43 | -- | 4.31 | -1.37 | -1.37 | 4.76 | 3.73 | 0.7247 | 2.08 | 7.87 | 391,322.80 | -20.87 | -29.02 | -22.75 | -32.98 | 73.31 | 72.91 | -28.80 | -46.84 | 9.62 | -- | 0.34 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
| Cytek Biosciences Inc | 193.01m | -12.15m | 816.46m | 676.00 | -- | 2.07 | -- | 4.23 | -0.0887 | -0.0887 | 1.43 | 3.01 | 0.3807 | 1.53 | 3.68 | 285,523.70 | -2.40 | -- | -2.67 | -- | 56.69 | -- | -6.29 | -- | 5.89 | -- | 0.0056 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| BioLife Solutions Inc | 143.27m | -66.43m | 816.76m | 409.00 | -- | 2.41 | -- | 5.70 | -1.52 | -1.52 | 3.28 | 7.48 | 0.332 | 2.46 | 5.45 | 350,298.30 | -15.40 | -13.76 | -17.12 | -15.04 | 32.63 | 36.76 | -46.36 | -42.99 | 1.83 | -30.52 | 0.0733 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Artivion Inc | 354.00m | -30.57m | 872.99m | 1.50k | -- | 3.05 | -- | 2.47 | -0.7496 | -0.7496 | 8.68 | 6.86 | 0.4553 | 1.60 | 5.30 | 236,002.70 | -3.95 | -2.20 | -4.24 | -2.36 | 64.74 | 65.51 | -8.67 | -5.34 | 3.43 | 0.6809 | 0.5246 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| Paragon 28 Inc | 216.39m | -47.84m | 873.00m | 430.00 | -- | 4.91 | -- | 4.03 | -0.5819 | -0.5819 | 2.64 | 2.15 | 0.7276 | 0.5484 | 5.77 | 503,230.20 | -16.09 | -- | -20.14 | -- | 79.85 | -- | -22.11 | -- | 2.30 | -7.22 | 0.3832 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Avanos Medical Inc | 673.30m | -9.90m | 909.30m | 3.77k | -- | 0.735 | 25.12 | 1.35 | -0.2092 | -1.32 | 14.43 | 26.77 | 0.387 | 1.66 | 4.73 | 178,546.80 | -0.5691 | -0.6527 | -0.6473 | -0.7338 | 56.39 | 54.45 | -1.47 | -1.60 | 1.38 | 4.27 | 0.1196 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| AtriCure Inc | 414.60m | -37.23m | 1.01bn | 1.20k | -- | 2.21 | -- | 2.44 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -13.41 | 0.1194 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Perspective Therapeutics Inc | 8.17m | -25.10m | 1.06bn | 88.00 | -- | 5.14 | -- | 130.07 | -0.1012 | -0.1012 | 0.0351 | 0.352 | 0.0944 | 4.91 | 5.55 | 92,852.27 | -29.01 | -- | -31.19 | -- | 22.96 | -- | -307.18 | -- | 2.55 | -- | 0.0173 | -- | -- | -- | -- | -- | -- | -- |
| MiMedx Group Inc | 321.48m | 55.80m | 1.09bn | 895.00 | 28.56 | 7.55 | 16.97 | 3.38 | 0.2581 | 0.2192 | 2.19 | 0.976 | 1.57 | 3.19 | 6.63 | 359,192.20 | 32.86 | -4.14 | 42.03 | -5.90 | 83.01 | 83.61 | 20.98 | -2.70 | 3.11 | 7.11 | 0.256 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| Coretag Inc | 0.00 | -39.35k | 1.13bn | -- | -- | -- | -- | -- | -0.4372 | -0.4372 | 0.00 | -0.93 | 0.00 | -- | -- | -- | -78,700.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| Adapthealth Corp | 3.20bn | -678.90m | 1.37bn | 10.70k | -- | 0.9331 | -- | 0.4294 | -5.06 | -5.06 | 23.77 | 11.00 | 0.6579 | 21.79 | 8.56 | 299,082.00 | -13.87 | -4.34 | -15.48 | -4.89 | 17.82 | 18.28 | -21.09 | -6.47 | 0.997 | 1.83 | 0.5978 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Owens & Minor, Inc. | 10.42bn | -38.77m | 1.39bn | 13.70k | -- | 1.56 | 5.54 | 0.1338 | -0.5131 | -0.5131 | 137.36 | 11.68 | 1.98 | 6.79 | 14.60 | 760,861.20 | -0.7372 | 1.32 | -1.11 | 2.07 | 20.75 | 16.48 | -0.3719 | 0.5614 | 0.5648 | 2.19 | 0.7065 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
Data as of May 04 2024. Currency figures normalised to Perspective Therapeutics Inc's reporting currency: US Dollar USD
12.56%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Commodore Capital LPas of 11 Apr 2024 | 38.91m | 6.63% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 13.14m | 2.24% |
| Baker Bros. Advisors LPas of 31 Dec 2023 | 7.64m | 1.30% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 4.54m | 0.77% |
| Geode Capital Management LLCas of 31 Dec 2023 | 2.52m | 0.43% |
| Alphacentric Advisors LLCas of 31 Mar 2024 | 1.76m | 0.30% |
| Ghost Tree Capital LLCas of 31 Dec 2023 | 1.60m | 0.27% |
| Osterweis Capital Management, Inc.as of 31 Dec 2023 | 1.58m | 0.27% |
| HighTower Advisors LLCas of 31 Dec 2023 | 1.33m | 0.23% |
| Perkins Capital Management, Inc.as of 31 Dec 2023 | 700.00k | 0.12% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
